Respiratory Infections News

Early data from trials assessing the new Pfizer and BioNTech omicron-adapted booster vaccine show that the vaccine substantially increased protective antibodies against the BA.5 subvariant in adults.

The FDA has granted an emergency use authorization for booster doses of Moderna and Pfizer-BioNTech’s omicron BA.4/BA.5-adapted bivalent COVID-19 vaccines for children and adolescents, both companies announced today.

Myocarditis and pericarditis after COVID-19 vaccination is rare across demographic groups and most likely to occur in teen boys in the week after their second shot of a two-dose vaccine, according to a study.

Readmission within 30 days of discharge was common among survivors of COVID-19, and more so in those with comorbidities, researchers found.

ANAHEIM, Calif. — Anne Schuchat, MD, former principal deputy director of the CDC, has a message for pediatricians.

In the United States, COVID-19 vaccinations may have prevented more than 650,000 hospitalizations and 300,000 deaths among Medicare beneficiaries in 2021, according to a new report from HHS.

Of patients being treated for Mycobacterium avium complex and Mycobacterium abscessus pulmonary infection, fewer than half received guideline-based treatment, according to a recent study.

People who received a booster dose of the COVID-19 vaccine had reduced symptom severity and duration across delta and omicron variant predominance, according to data from the COVID-Out trial.

Following last year’s mild influenza season, U.S. officials are emphasizing the importance of influenza, pneumococcal and COVID-19 vaccinations as they expect a much more severe season in the weeks to come.

Although the general understanding of long COVID has improved in the past year, many questions about the persistent sequelae experienced by some people after an acute SARS-CoV-2 infection remain, according to experts.